Bilheimer D W, Watanabe Y, Kita T
Proc Natl Acad Sci U S A. 1982 May;79(10):3305-9. doi: 10.1073/pnas.79.10.3305.
The homozygous WHHL (Watanabe heritable hyperlipidemic) rabbit displays either no or only minimal low density lipoprotein (LDL) receptor activity on cultured fibroblasts and liver membranes and has therefore been proposed as an animal model for human familial hypercholesterolemia. To assess the impact of this mutation on LDL metabolism in vivo, we performed lipoprotein turnover studies in normal and WHHL rabbits using both native rabbit LDL and chemically modified LDL (i.e., methyl-LDL) that does not bind to LDL receptors. The total fractional catabolic rate (FCR) for LDL in the normal rabbit was 3.5-fold greater than in the WHHL rabbit. Sixty-seven percent of the total FCR for LDL in the normal rabbit was due to LDL receptor-mediated clearance and 33% was attributable to receptor-independent processes; in the WHHL rabbit, essentially all of the LDL was catabolized via receptor-independent processes. Despite a 17.5-fold elevated plasma pool size of LDL apoprotein (apo-LDL) in WHHL as compared to normal rabbits, the receptor-independent FCR-as judged by the turnover of methyl-LDL-was similar in the two strains. Thus, the receptor-independent catabolic processes are not influenced by the mutation affecting the LDL receptor. The WHHL rabbits also exhibited a 5.6-fold increase in the absolute rate of apo-LDL synthesis and catabolism. In absolute terms, the WHHL rabbit cleared 19-fold more apo-LDL via receptor-independent processes than did the normal rabbit and cleared virtually none by the receptor-dependent pathway. These results indicate that the homozygous WHHL rabbit shares a number of metabolic features in common with human familial hypercholesterolemia and should serve as a useful model for the study of altered lipoprotein metabolism associated with receptor abnormalities. We also noted that the in vivo metabolic behavior of human and rabbit LDL in the normal rabbit differed such that the mean total FCR for human LDL was only 64% of the mean total FCR for rabbit LDL, whereas human and rabbit methyl-LDL were cleared at identical rates. Thus, if human LDL and methyl-LDL had been used in these studies, the magnitude of both the total and receptor-dependent FCR would have been underestimated.
纯合子WHHL(渡边遗传性高脂血症)兔在培养的成纤维细胞和肝细胞膜上要么没有低密度脂蛋白(LDL)受体活性,要么只有极低的活性,因此被提议作为人类家族性高胆固醇血症的动物模型。为了评估这种突变对体内LDL代谢的影响,我们使用天然兔LDL和不与LDL受体结合的化学修饰LDL(即甲基化LDL),在正常兔和WHHL兔中进行了脂蛋白周转研究。正常兔中LDL的总分数分解代谢率(FCR)比WHHL兔高3.5倍。正常兔中LDL总FCR的67%归因于LDL受体介导的清除,33%归因于非受体依赖过程;在WHHL兔中,基本上所有的LDL都是通过非受体依赖过程分解代谢的。尽管与正常兔相比,WHHL兔中LDL载脂蛋白(apo-LDL)的血浆池大小增加了17.5倍,但通过甲基化LDL周转判断的非受体依赖FCR在两个品系中相似。因此,非受体依赖的分解代谢过程不受影响LDL受体的突变的影响。WHHL兔的apo-LDL合成和分解代谢的绝对速率也增加了5.6倍。从绝对值来看,WHHL兔通过非受体依赖过程清除的apo-LDL比正常兔多19倍,而通过受体依赖途径几乎没有清除。这些结果表明,纯合子WHHL兔与人类家族性高胆固醇血症有许多共同的代谢特征,应该作为研究与受体异常相关的脂蛋白代谢改变的有用模型。我们还注意到,正常兔中人类和兔LDL的体内代谢行为不同,因此人类LDL的平均总FCR仅为兔LDL平均总FCR的64%,而人类和兔甲基化LDL以相同的速率清除。因此,如果在这些研究中使用人类LDL和甲基化LDL,总FCR和受体依赖FCR的幅度都会被低估。